MoonLake Immunotherapeutics (MLTX)
10.58
-0.19
(-1.76%)
USD |
NASDAQ |
Oct 08, 16:00
10.58
0.00 (0.00%)
After-Hours: 16:47
MoonLake Immunotherapeutics EPS Diluted (Quarterly) : -0.8362 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8362 |
| March 31, 2026 | -0.978 |
| December 31, 2025 | -0.9212 |
| September 30, 2025 | -1.100 |
| June 30, 2025 | -0.8726 |
| March 31, 2025 | -0.6317 |
| December 31, 2024 | -0.7231 |
| September 30, 2024 | -0.5627 |
| June 30, 2024 | -0.386 |
| March 31, 2024 | -0.2183 |
| December 31, 2023 | -0.1241 |
| September 30, 2023 | -0.1761 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.2319 |
| March 31, 2023 | -0.2305 |
| December 31, 2022 | -0.3054 |
| September 30, 2022 | -0.2738 |
| June 30, 2022 | -0.3443 |
| March 31, 2022 | -3.167 |
| December 31, 2021 | -1.401 |
| September 30, 2021 | -2.630 |
| June 30, 2021 | -2.898 |
| March 31, 2021 | -0.0052 |
| December 31, 2020 | -0.0058 |
| September 30, 2020 | -0.0003 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 2.050 |
| AC Immune SA | 0.026 |
| CRISPR Therapeutics AG | -0.9445 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.80M |
| Total Expenses (Quarterly) | 61.80M |
| Enterprise Value | 464.95M |
| Earnings Yield | -36.26% |
| Normalized Earnings Yield | -36.25 |